Johnson & Johnson’s $2B Plant Boosts Wilson Jobsby Mark Eisenberg 02.10.2024Johnson & Johnson's $2 billion investment in Wilson will create 420 jobs, boosting the local economy and life sciences sector.
AI Centers of Excellence Propel Innovation Forwardby Lilu Anderson 26.09.2024Discover how AI Centers of Excellence enhance scalability, security, and innovation at Johnson & Johnson.
Mars’ $36B Acquisition of Kellanova Lifts Stocksby Mark Eisenberg 17.08.2024Mars' acquisition of Kellanova boosts grocery stocks amid inflation and regulatory scrutiny in the food industry.
Defensive Stocks: Morgan Stanley’s Top Picksby Mark Eisenberg 14.08.2024Explore Morgan Stanley's top defensive stock picks for stable investments amid market volatility. Learn strategies to protect your portfolio.
J&J Faces New Class Action: Medical Monitoring for Talc Usersby Mark Eisenberg 19.06.2024Johnson & Johnson faces a new class action lawsuit for talc products, demanding medical monitoring for cancer risk while opposing ...
2024 S&P 500: Top Growth Stocks to Watchby Terry Bingman 31.03.2024J&J's net sales reach $85 billion, up 7% from 2022, while Amazon reports profits of $30 billion on net sales ...
Boundless Bio Makes $100M IPO Debut on Nasdaqby Mark Eisenberg 28.03.2024Precision oncology company Boundless Bio is set to go public with a $100 million IPO on the Nasdaq, trading under ...
Accent Therapeutics secures J&J and BMS as new investors in $75M series Cby Mark Eisenberg 23.01.2024Pharmaceutical giants Bristol Myers Squibb and Johnson & Johnson invest in Accent Therapeutics, a leading RNA drug developer, contributing to ...
Investors Reap Massive Gains in J&J’s Acquisition of Ambrxby Terry Bingman 09.01.2024Johnson & Johnson's acquisition of Ambrx showcases the power of biotech M&A, rewarding investors with staggering returns and highlighting the ...
Johnson & Johnson’s $2 Billion Acquisition of Ambrx Biopharma: A Major Investment in Biotechnologyby Mark Eisenberg 08.01.2024Johnson & Johnson's $2 billion acquisition of Ambrx Biopharma emphasizes its focus on oncology and targeted cancer treatments. #PharmaNews